Purchase Order 75N95021P00443
Award Date 9/1/21
Potential Completion Date 8/31/23
Potential Value $197K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Cary, NC 27513, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $97,106.08 firm fixed price purchase order award by the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS), to Virscidian Inc. for the renewal of a subscription to the Virscidian Analytical Studio Express - Instrument Agent software package. The award is non-competitive and was issued without full and open competition due to exclusive licensing agreements for this...
- This is a $15,944 firm fixed price purchase order awarded to Virscidian Inc. by the National Center for Advancing Translational Sciences (NCATS), a component of the U.S. Department of Health and Human Services. The contract is for the provision of a professional floating license subscription for Virscidian's Analytical Studio software package, which provides customized analytical software solutions. This award has no set-aside designation and is a continuation of prior awards to Virscidian...
- This is a $209,130 firm fixed price purchase order awarded by the National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) to Virscidian Inc. for a 1-year subscription to the Virscidian Analytical Studio Express - Instrument Agent software with an option for an additional 1-year subscription. The contract has no set-aside designation and is a sole source award, as Virscidian Inc. is the exclusive provider of this proprietary software. This award is a...
- This is a firm fixed price purchase order award from the National Institutes of Health National Center for Advancing Translational Sciences (NCATS) to Virscidian Inc., a for-profit software company, for the Virscidian Analytical Studio Express - Instrument Agent software package. The $97,106.08 award has a completion date of August 31, 2020 and is a non-competitive sole source contract with no set-aside designation. The solicitation was specifically for this software package, which provides...
- The U.S. Food and Drug Administration (FDA) awarded a $633,133.00 firm-fixed-price purchase order contract to Virscidian Inc., a small business, for the provision of Analytical Studio Express Software and Support. The contract has a completion date of May 26, 2015 and was awarded on May 26, 2011. Virscidian Inc. is a company that specializes in customized analytical software solutions, and this contract is part of a larger set of awards the company has received from the Department of Health...
- This is a $112,000.00 Firm Fixed Price federal contract awarded by the Food and Drug Administration (FDA) to Virscidian Inc., a small business contractor, for the development of analytical studio software. The contract has a period of performance through September 20, 2016. Virscidian Inc. specializes in customized analytical software solutions and has received multiple prior contract awards from the National Institutes of Health National Center for Advancing Translational Sciences for the...
- The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences awarded a firm-fixed price purchase order to Fisher Scientific Company L.L.C. valued at $24,010.95 to provide multiple formulation-related laboratory tools and equipment. The solicitation requested brand name or equal laboratory items to support the agency's research and development efforts. Performance will take place in Potomac, Maryland over a three-month period...
- The U.S. National Center for Advancing Translational Sciences (NCATS), a civilian agency within the Department of Health and Human Services (HHS), awarded a $225,000.00 Firm Fixed Price Definitive Contract to Invivosciences, Inc., a small disadvantaged business, for "PHENOTYPIC CARDIOTOXICITY SCREENING WITH HUMAN 3D HEART TISSUES". This award is set aside for total small business participation. Invivosciences provides research and development services in the field of medical science,...
- The National Center for Advancing Translational Sciences (NCATS) awarded a $52,623.05 firm fixed price delivery order to Vinsys Information Technology, Inc., a certified 8(a) small disadvantaged business headquartered in Sterling, Virginia. This total small business set-aside contract, with an ultimate completion date of February 3, 2027, covers Atlassian software and associated equipment to support NCATS operations. The award was issued on February 4, 2026, and performance will take place in...
- The National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), awarded a $26,870 sole-source purchase order to Caerus US 1 Inc., operating as Citeline, to provide five one-year licenses for its Biomedtracker database and five one-year licenses for the Enhanced Company Deals Upgrade. These software tools will support NCATS' work on intellectual property issues, patent filing, and industry partnerships by providing access to a comprehensive...